- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01628887
Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors
July 12, 2013 updated by: City of Hope Medical Center
This clinical trial studies a supportive education program for Latina breast cancer survivors.
The Bilingual Breast Cancer Education Intervention (BBCEI) may help Latina breast cancer survivors know what to expect after completing breast cancer treatment and prepare them to cope with cancer related survivorship issues
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES: I. Describe the feasibility of implementing the BBCEI.
II.
Describe the cultural and linguistic appropriateness of the BBCEI.
III.
Determine topics requiring further emphasis in the BBCEI.
IV.
Identify ways to enhance program content, format, and materials.
OUTLINE: Participants undergo 2 tailored BBCEI sessions within 1 month.
At the beginning of the first session the research nurse will present the participants with a list of common physical and social concerns.
The participant will then be asked to identify 3 topics that she wants to discuss.
The research nurse will discuss with the participant any relevant supportive care resources and make the appropriate referrals.
At the second session the focus of the BBCEI will be on psychological and spiritual well-being.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Duarte, California, United States, 91010
- City of Hope Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
The population will consist of Latinas with breast cancer who have completed primary cancer treatment. A total of 10 subjects will be accrued.
Inclusion Criteria:
- Diagnosis of Stage I, II or III.
- Self-identification as Hispanic/Latina.
- Able to read and understand English or Spanish to participate in the education sessions.
- Ability to read and/or understand the study protocol requirements, and provide written informed consent
- Subjects maybe be on hormonal therapy after treatment for initial breast cancer.
Exclusion Criteria:
- Actively receiving treatment with surgery, radiation therapy, or chemotherapy.
- Patients who have recurrence, metastasis, or a second primary cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Supportive Care (BBCEI)
Participants undergo 2 tailored BBCEI sessions within 1 month.
At the beginning of the first session the research nurse will present the participants with a list of common physical and social concerns.
The participant will then be asked to identify 3 topics that she wants to discuss.
The research nurse will discuss with the participant any relevant supportive care resources and make the appropriate referrals.
At the second session the focus of the BBCEI will be on psychological and spiritual well-being.
|
Undergo Bilingual Breast Cancer Educational Intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the feasibility of implementation of a Bilingual Breast Cancer Education Intervention (BBCEI)
Time Frame: 2 months after completion of the educational session
|
A semi-structured interview guide will be used to describe participant satisfaction with the BBCEI.
It allows the patient to describe in their own words whether the BBCEI was effective for their QOL concerns, helpfulness of intervention content, describe the cultural and linguistic appropriateness and identify ways to enhance program content, format and materials.
|
2 months after completion of the educational session
|
|
Determine the cultural and linguistic appropriateness of the BBCEI
Time Frame: 2 months after completion of the educational session
|
A semi-structured interview guide will be used to describe participant satisfaction with the BBCEI.
It allows the patient to describe in their own words whether the BBCEI was effective for their QOL concerns, helpfulness of intervention content, describe the cultural and linguistic appropriateness and identify ways to enhance program content, format and materials
|
2 months after completion of the educational session
|
|
Determine topics requiring further emphasis in the BBCEI
Time Frame: 2 months after completion of the educational session
|
A semi-structured interview guide will be used to describe participant satisfaction with the BBCEI.
It allows the patient to describe in their own words whether the BBCEI was effective for their QOL concerns, helpfulness of intervention content, describe the cultural and linguistic appropriateness and identify ways to enhance program content, format and materials
|
2 months after completion of the educational session
|
|
Determine ways to enhance program content, format and materials
Time Frame: 2 months after completion of the educational session
|
A semi-structured interview guide will be used to describe participant satisfaction with the BBCEI.
It allows the patient to describe in their own words whether the BBCEI was effective for their QOL concerns, helpfulness of intervention content, describe the cultural and linguistic appropriateness and identify ways to enhance program content, format and materials
|
2 months after completion of the educational session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gloria Juarez, PhD, City of Hope Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
June 25, 2012
First Submitted That Met QC Criteria
June 25, 2012
First Posted (Estimate)
June 27, 2012
Study Record Updates
Last Update Posted (Estimate)
July 16, 2013
Last Update Submitted That Met QC Criteria
July 12, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12175
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stage I Breast Cancer
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage IA Breast Cancer AJCC v8 | Prognostic Stage IB Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC...United States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Chemotherapy-Induced AlopeciaUnited States
-
Indiana University School of MedicineBreast Cancer Research FoundationCompletedQuantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer (EPC)Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage IIUnited States
-
Craig A. Bunnell, MD, MPHMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States
-
Mayo ClinicNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Cancer-related Cognitive DysfunctionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage IA Breast Cancer AJCC v8 | Prognostic Stage IB Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Prognostic...United States
-
St. Antonius HospitalRijnstate Hospital; Amphia Hospital; Antoni van Leeuwenhoek HospitalNot yet recruitingBreast Cancer Stage I | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Netherlands
Clinical Trials on Educational Intervention
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBacterial Infection | Clostridium DifficileUnited States
-
Universidad de GranadaNot yet recruitingAsthma | Allergy
-
Roswell Park Cancer InstituteCompletedCervical Cancer | Breast CancerUnited States
-
US Department of Veterans AffairsDuke UniversityCompletedAccidental FallsUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Azienda Unita Sanitaria Locale Reggio EmiliaCompletedMelanoma (Skin) | Educational ProblemsItaly
-
Goethe UniversityUnknownHealth Knowledge, Attitudes, PracticeGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | LymphedemaUnited States
-
McGill University Health Centre/Research Institute...University of Manitoba; Sunnybrook Health Sciences Centre; University of Alberta and other collaboratorsCompletedPeptic Ulcer Hemorrhage
-
Claudia AristizábalUniversidad Nacional de Colombia; Universidad de Santander; Fundación Universitaria...Enrolling by invitationBurnout, Psychological | CaregiversColombia